Pediatrics Articles

Pediatrics

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Son MBF et al. - This report provides the first large multicenter description of agents used in the treatment of intravenously administered immunoglobulin-resistant Kawasaki disease in the United States. Trends include increased numbers of admissions attributable to Kawasaki disease and increased usage of infliximab.

 

Related Articles

Six principal symptoms and coronary artery sequelae in Kawasaki disease
Pediatrics International, 10/07/09    Relevance Score: 69%

BTNL2 gene polymorphisms may be associated with susceptibility to Kawasaki disease and formation of coronary artery lesions in Taiwanese children
European Journal of Pediatrics, 11/05/09    Relevance Score: 67%

Rheumatic manifestations of Epstein-Barr virus in children
Journal of Pediatric Infectious Diseases, 11/02/09    Relevance Score: 67%

A unique plasma proteomic profiling with imbalanced fibrinogen cascade in patients with Kawasaki disease
Pediatric Allergy and Immunology, 10/26/09    Relevance Score: 66%

Transient unilateral oculomotor palsy and severe headache in childhood Kawasaki disease
Rheumatology International, 10/23/09    Relevance Score: 66%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address